Finnrick - Ensuring a Safer and More Transparent Supply Chain
Zhengzhou Lanyun

Zhengzhou Lanyun

Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from Zhengzhou Lanyun between 31 Dec 2025 and 4 Feb 2026. Test scores average over 7, no score below 6, and at least 6 tests warrant a confident Finnrick Rating of A (Great).

Finnrick Rating™
Zhengzhou Lanyun
Tirzepatide
Tested 6 Samples
Last test 4 Feb 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Zhengzhou Lanyun

Samples are tested in commercial labs

Tests Count

6

Scores

AVG8.2MIN6.2MAX10.0

Last

4 Feb 2026

First

31 Dec 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
4 Feb 2026View6.560mg65.9mg+9.8%99.90%n/a(no batch ID)No Label / Silver Crimp / Red CapLab GPublic
29 Jan 2026View7.860mg51.9mg-13.5%99.90%n/aDec 2,2025No Label / Silver Crimp / Orange CapLab EPublic
15 Jan 2026View9.860mg62.5mg+4.2%99.80%n/aDec 2,2025No Label / Silver Crimp / Orange CapLab GPublic
7 Jan 2026View6.230mg32.8mg+9.3%99.70%n/a(no batch ID)No Label / Silver Crimp / Red CapLab GPublic
2 Jan 2026View8.830mg32.7mg+9.0%99.92%
not detected
Oct 19,2025No Label / Silver Crimp / Violet Cap Lab EPublic
31 Dec 2025View10.060mg60.8mg+1.3%99.95%
below LOQ
Oct 8,2025No Label / Silver Crimp / Pink Cap Lab EPublic